Oruka Therapeutics, Inc. (ORKA) — 10-K Filings
All 10-K filings from Oruka Therapeutics, Inc.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
Oruka Therapeutics Files 2024 Annual Report
— Mar 6, 2025 Risk: low
Oruka Therapeutics, Inc. filed its annual report on Form 10-K for the fiscal year ended December 31, 2024. The company, previously known as ARCA biopharma, Inc. -
ARCA biopharma, Inc. Files 2023 Annual Report on Form 10-K
— Feb 1, 2024 Risk: medium
ARCA biopharma, Inc. (ORKA) filed a Annual Report (10-K) with the SEC on February 1, 2024. ARCA biopharma, Inc. (ORKA) filed its 2023 Form 10-K on February 1, 2
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX